HIV/AIDS Therapy
Investigators at University of California have published new data on HIV/AIDS therapy
Published in AIDS Weekly, June 11th, 2007
A new study, "Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort," is now available. "Since protease inhibitors (PIs) were first introduced in 1995, research has shown that use of PIs greatly improves rates of survival, while slowing HIV disease progression. However, there are concerns that use of PIs may be associated with an increased risk of cardiovascular disease (CVD)," researchers in the United States report.
"To examine the relationship between PI use and CVD among HIV-infected patients, a large retrospective/prospective observational study was conducted. The study population was a clinic-based...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-06-11)
More Articles from AIDS Weekly
- HIV/AIDS
New Study Suggests Potential for a Broadly-Protective HIV Vaccine - HIV/AIDS
Treating HIV in war zones -- Public health emergencies need rapid advice from WHO - HIV/AIDS Co-Infection
Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths - HIV/AIDS
Activists to Crist: 'Be the Governor for People with AIDS,' Says AHF - HIV/AIDS
Avexa Wins $4.3m Commercial Ready Grant for Anti-HIV Drug Discovery Program - HIV/AIDS
Bush AIDS Proposal an Important Step, but not a Doubling of Current Funding - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
